Test Price
2,000 AED✅ Home Collection Available
Amikacin Therapeutic Drug Monitoring Test in UAE | 2000 AED | 2026 DHA Guidelines
تحليل أميكاسين في الإمارات | 2000 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي
- ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة من ISO 9001:2015.
- الخدمات اللوجستية المتميزة: سحب منزلي على مستوى المستشفيات بنظام سلسلة التبريد المعتمدة ISO، وخدمة الفصد المتنقلة VIP.
- التوجيه الطبي: استشارة سريرية هاتفية بعد الفحص لتفسير النتائج.
- التأمين: التحقق المباشر من التغطية التأمينية عبر واتساب +971545488731.
Test Overview: Precision in Aminoglycoside Monitoring
The Amikacin test, a cornerstone of Therapeutic Drug Monitoring (TDM), measures serum amikacin levels to optimize dosing and prevent nephrotoxicity or ototoxicity in life‑threatening Gram‑negative infections. In the UAE, our DHA‑guided immunoassay ensures rapid, accurate trough/peak analysis, aligning with 2026 federal standards.
| Feature | Our Advanced Test | Conventional Alternative |
|---|---|---|
| Analytical Precision | Quantitative Immunoassay (PETINIA) – intra‑assay CV <4% | Non‑specific bioassay |
| Sample Economy | 1 mL serum (red‑top tube), refrigerated/frozen | Larger volumes, less stability |
| Turnaround Time | Report in 2–3 weeks* (batch‑processed internationally) | Often >4 weeks with lower traceability |
*Samples collected by the 7th of the month; report delivered within 2‑3 weeks via secure portal.
Physician Insight & Safety from Dr. PRABHAKAR REDDY (DHA 61713011)
“As a clinical pathologist overseeing therapeutic drug monitoring, I emphasize that an isolated amikacin level must be interpreted within the full clinical picture. Always correlate with renal function, dosing schedule, and infection status. A result in the expected range reassures therapeutic adequacy, but never replace vigilant clinical observation – especially in neonates and patients with compromised kidney function.”
⚠️ Critical Safety Alert
- Do not discontinue prescribed amikacin or any medication without direct consultation with your treating physician. Abrupt cessation can lead to resistant infections or clinical deterioration.
- Exclusion Criteria for Home Collection: Refusal to sign the mandatory Test Send Out Consent Form (Form 35); inability to maintain cold‑chain during transport; known coagulopathy without medical clearance.
- Emergency Red Flags: Seek immediate medical attention if you experience new‑onset tinnitus, vertigo, oliguria, or rash after sampling – these may indicate ototoxicity or anaphylaxis.
Patient Frequently Asked Questions
What does the amikacin test tell my doctor about my treatment?
The amikacin test quantifies the drug concentration in your blood at the critical trough (lowest) and peak (highest) times, directly enabling your nephrologist or neonatologist to adjust the dose precisely, preventing toxic accumulation while ensuring the antibiotic eliminates the bacteria causing your serious infection. This monitoring is essential for patients receiving prolonged aminoglycoside therapy, especially those with changing kidney function.
متى يجب أن أتوقف عن أخذ عينة الأميكاسين؟
لا تتوقف أبداً عن أخذ العينة بناءً على تعليمات طبيبك؛ يجب سحب العينة في وقت الذروة المحدد (عادةً 30-60 دقيقة بعد التسريب الوريدي أو 60 دقيقة بعد الحقن العضلي) وفي وقت القاع (مباشرة قبل الجرعة التالية) لضمان دقة التقييم الدوائي. إن تغيير الجدول بدون استشارة طبية قد يؤدي إلى جرعات غير آمنة أو علاج غير فعال، مما يعرض صحتك للخطر.
Why does the take 2–3 weeks and what happens during that time?
Because the blood sample is processed in a specialized international reference laboratory adhering to ISO 9001:2015 standards, the 2–3 week window allows for cold‑chain shipment, batch immunoassay analysis, and rigorous two‑step quality control review before your physician receives the traceable report. This interval is a trade‑off for superior accuracy and cost‑effectiveness; your clinical team can still make interim adjustments based on your clinical progress.
Fully compliant with Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE Child Data Sensitivity Law (2026), and UAE PDPL. Your personal health information is protected and processed only for clinical care purposes.
Facility License: 9834453 | ISO 9001:2015 Certificate: INT/EGQ/2509DA/3139 | Support: WhatsApp +971545488731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians